← Eichor
Condition: Irritable Bowel Syndrome With Constipation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Irritable Bowel Syndrome With Constipation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Phase 2 · 70 location(s) · Eli Lilly and Company · NCT07545772
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NA · 1 location(s) · University of Michigan · NCT03687814
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05803993
The Beneficial Effects on the Intestinal Function of a Food Supplement Based on an Extract of Green Tea and a Pool of Pr
NA · 1 location(s) · Adamas Biotech S.r.l. · NCT07094035
A Study of Virtual Reality and Linaclotide for IBS-C
NA · 1 location(s) · Mayo Clinic · NCT05796388
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predo
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06801184
Home Transcutaneous Electrical Acustimulation (TEA)
Phase 2/Phase 3 · 1 location(s) · University of Michigan · NCT05519683
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.